Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: Relief from immunosuppression is associated with clinical response

by Botticelli, A., Cortesi, E., Di Filippo, A., Marchetti, P., Napoletano, C., Nuti, M., Rughetti, A., Scagnoli, S., Scirocchi, F., Strigari, L., Tomao, S., Zizzari, I.G
Published 2022